Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NewMed Energy LPDKDRF 77 Piotroski F-Score is 4 as of Aug. 28, 2026, which is 33% below its 10-year median of 6.00. GuruFocus rates DKDRF with a GF Score™ of 77/100 and a GF Value™ of $3.77 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 991 Oil & Gas companies, NewMed Energy LP ranks worse than 61.96% on this metric.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
NewMed Energy LP has an F-score of 4 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for NewMed Energy LP's Piotroski F-Score or its related term are showing as below:
DKDRF'
s Piotroski F-Score Range Over the Past 10 Years
Min: 4 Med: 6 Max: 9
Current: 4
During the past 13 years, the highest Piotroski F-Score of NewMed Energy LP was 9. The lowest was 4. And the median was 6.
NewMed Energy LP (OTCPK:DKDRF) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
NewMed Energy LP Piotroski F-Score Related Terms
NewMed Energy LP Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for NewMed Energy LP's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DKDRF vs COP, EOG, FANG: Piotroski F-Score Comparison
For the Oil & Gas E&P subindustry, NewMed Energy LP's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NewMed Energy LP Piotroski F-Score vs Oil & Gas Industry
For the Oil & Gas industry and Energy sector, NewMed Energy LP's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where NewMed Energy LP's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
NewMed Energy LP's current Net Income (TTM) was 263.3.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
NewMed Energy LP's return on assets of this year was 0.06653358. NewMed Energy LP's return on assets of last year was 0.11875032.
==> Last year is higher ==> Score 0.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
NewMed Energy LP's gearing of this year was 0.25423856. NewMed Energy LP's gearing of last year was 0.35461756.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
NewMed Energy LP's current ratio of this year was 0.77451129. NewMed Energy LP's current ratio of last year was 2.95324074.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
NewMed Energy LP's number of shares in issue this year was 1176.094. NewMed Energy LP's number of shares in issue last year was 1175.306.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
NewMed Energy LP's gross margin of this year was 0.4254417. NewMed Energy LP's gross margin of last year was 0.62889036.
==> Last year's gross margin is higher ==> Score 0.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
NewMed Energy LP's asset turnover of this year was 0.25029059. NewMed Energy LP's asset turnover of last year was 0.27048258.
==> Last year's asset turnover is higher ==> Score 0.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
0
+
1
+
1
+
0
+
0
+
0
+
0
=
4
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
NewMed Energy LP has an F-score of 4 indicating the company's financial situation is typical for a stable company.
NewMed Energy LP (DKDRF) has a Piotroski F-Score of 4 as of Aug. 28, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on NewMed Energy LP and its competitors. This is 33% below median its historical median of 6.00. Over the past decade, NewMed Energy LP's Piotroski F-Score has ranged from 4.00 to 9.00. According to the industry distribution chart, NewMed Energy LP ranks #614 out of 991 companies in the Oil & Gas industry, placing it in the top 62%.
Is NewMed Energy LP's Piotroski F-Score too high?
NewMed Energy LP's current Piotroski F-Score of 4 is 33% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 9.00. The Oil & Gas industry median Piotroski F-Score is 5.00. NewMed Energy LP's value of 4 is 20% below this industry median. Based on the distribution chart, NewMed Energy LP ranks #614 out of 991 companies in the Oil & Gas industry, which is below the industry midpoint. Overall, NewMed Energy LP has a GF Score™ of 77/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NewMed Energy LP's Piotroski F-Score compare to COP and EOG?
According to the Oil & Gas industry distribution chart, NewMed Energy LP ranks #614 out of 991 companies for Piotroski F-Score. This places NewMed Energy LP in the lower half of its industry. The industry median Piotroski F-Score is 5.00. NewMed Energy LP's value of 4 is 20% below this benchmark. Historically, NewMed Energy LP's own Piotroski F-Score has ranged from 4.00 to 9.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, NewMed Energy LP has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for an Oil & Gas company?
The median Piotroski F-Score among Oil & Gas companies is 5.00, based on 991 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NewMed Energy LP's current Piotroski F-Score of 4 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on NewMed Energy LP and its competitors. For the Oil & Gas industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NewMed Energy LP's current Piotroski F-Score is 4, which is 33% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NewMed Energy LP stock overvalued right now?
Based on GuruFocus' analysis, NewMed Energy LP (DKDRF) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.77, compared to a current price of $5.40 — trading 43.2% above its estimated fair value. The current Piotroski F-Score is 4, which is 33% below median its 10-year median of 6.00 and 20% below the Oil & Gas industry median of 5.00. NewMed Energy LP's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For NewMed Energy LP (DKDRF), the current Piotroski F-Score is 4 as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NewMed Energy LP (DKDRF) Overvalued in 2026?
Based on GuruFocus' analysis, NewMed Energy LP stock appears to be overvalued.
The current stock price of $5.40 is trading 43.2% above its estimated GF Value™ of $3.77.
GuruFocus considers NewMed Energy LP to be Significantly Overvalued.
Key valuation signals for DKDRF:
Piotroski F-Score: 4 (33% below median its 10-year median of 6.00)
GF Value™: $3.77 vs. price of $5.40 (43.2% above fair value)
Industry Position: 20% below the Oil & Gas median (#614 of 991)
No single metric tells the full story. See the DKDRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NewMed Energy LP operates in the energy field. Its primary business is exploring, developing, producing, and marketing natural gas, condensate, and oil in Israel and Cyprus and promoting various natural gas-based projects. The Partnership aims to increase the volume of its natural gas sales.
77GF Score
Get the complete analysis for DKDRF
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DKDRF has been successfully added to your 
